RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EFTR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for eFFECTOR Therapeutics, Inc. stock price on Wednesday moving between $12.38 and $13.72
(Updated on Mar 27, 2024)

Buy candidate since Mar 25, 2024 Loss -2.25% PDF

The eFFECTOR Therapeutics, Inc. stock price gained 4.18% on the last trading day (Wednesday, 27th Mar 2024), rising from $12.91 to $13.45. During the last trading day the stock fluctuated 10.82% from a day low at $12.38 to a day high of $13.72. The price has risen in 7 of the last 10 days and is up by 23.62% over the past 2 weeks. Volume fell on the last day by -323 thousand shares and in total, 164 thousand shares were bought and sold for approximately $2.21 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 129.02% during the next 3 months and, with a 90% probability hold a price between $23.00 and $46.05 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EFTR Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Monday, March 04, 2024, and so far it has fallen -20.65%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). The eFFECTOR Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $12.93 and $12.45. A breakdown below any of these levels will issue sell signals. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for eFFECTOR Therapeutics, Inc. stock

eFFECTOR Therapeutics, Inc. finds support from accumulated volume at $13.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.34 between high and low, or 10.82%. For the last week, the stock has had daily average volatility of 13.22%.

Our recommended stop-loss: $12.79 (-4.90%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 17 days ago.)

Trading Expectations (EFTR) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect eFFECTOR Therapeutics, Inc. to open at $13.18, and during the day (based on 14 day Average True Range), to move between $11.98 and $14.92, which gives a possible trading interval of +/-$1.47 (+/-10.91%) up or down from last closing price. If eFFECTOR Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 21.82% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $13.59 (1.04%) than the support at $13.16 (2.16%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is eFFECTOR Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for eFFECTOR Therapeutics, Inc. stock to perform well in the short-term.

Current score: 4.331 Buy Candidate Unchanged

Predicted Opening Price for eFFECTOR Therapeutics, Inc. of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$13.18 ( 1.98%) $13.45

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EFTR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 14.52 7.98 %
R2 14.01 4.17 %
R1 13.70 1.82 %
Current price: 13.45
Support S1 12.67 -5.79 %
S2 12.36 -8.14 %
S3 11.84 -11.95 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 16.20 20.45 %
R2 13.76 2.30 %
R1 13.59 1.04 %
Current price 13.45
Support S1 13.16 -2.16%
S2 12.91 -4.01%
S3 11.12 -17.32%

FAQ

What is the symbol for eFFECTOR Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for eFFECTOR Therapeutics, Inc. is EFTR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell eFFECTOR Therapeutics, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for eFFECTOR Therapeutics, Inc. stock to perform well in the short-term.

How to buy eFFECTOR Therapeutics, Inc. Stock?
eFFECTOR Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy eFFECTOR Therapeutics, Inc. Stock.

What's the current price of eFFECTOR Therapeutics, Inc. Stock?
As of the end of day on the 2024-03-27, the price of an eFFECTOR Therapeutics, Inc. (EFTR) share was $13.45.

What is the 52-week high and low for eFFECTOR Therapeutics, Inc. Stock?
The 52-week high for eFFECTOR Therapeutics, Inc. Stock is $17.75 and the 52-week low is $0.338.

What is the market capitalization of eFFECTOR Therapeutics, Inc. Stock?
As of the 2024-03-27, the market capitalization of eFFECTOR Therapeutics, Inc. is 34.767M.

When is the next earnings date for eFFECTOR Therapeutics, Inc.?
The upcoming earnings date for eFFECTOR Therapeutics, Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About eFFECTOR Therapeutics, Inc.

eFFECTOR Therapeutics. eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing Zotatifin, a small molecule designed to inhibit euk... EFTR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT